diabeticmediterraneandiet.com
FDA Approves Another GLP-1 Receptor Agonist Drug for Type 2 Diabetes
The most common side effects are nausea, vomiting, diarrhea, headaches, and dizziness. “The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improv…